Accretion Nutraveda Ltd (544694) — Voting Results | 27 August 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
All 10 AGM resolutions passed with unanimous shareholder approval via e-voting and in-person polling.
🔄 What Changed
Unanimous approval of all resolutions including financial statements, director appointments, and executive remuneration revisions.
💡 Investor Takeaway
Shareholders overwhelmingly endorsed all proposed governance and compensation measures with no opposition.

Accretion Nutraveda shareholders approved all 10 AGM resolutions via remote e-voting and in-person polling on August 27, 2026, including financial statements, director appointments, and executive remuneration revisions. The voting results confirm unanimous approval with zero dissenting votes across all items.

📄 View Original Announcement (PDF)

About Accretion Nutraveda Ltd (544694)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹201.42 Cr

View full 544694 stock details →

📡 Get AI alerts when 544694 files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track 544694 — Free

📊 More 544694 filings

See all 544694 filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts for your stocks — summarized by AI daily

Set up your AI Radar — pick stocks, get daily email summaries of new filings.

Set up AI Radar — Free

Free account · 2 AI queries/day